Lazio's anti-waste line aims not to throw away even a drop of serum and to cut waiting times.Don't store avocado like this: it's dangerous
They call them "benches", taking up the purely football jargon, and they are those who receive a dose of vaccine that on a certain day was intended for people who did not show up for the appointment with the administration. In fact, about 10% of those booked in the event do not show up and so, with this new method, the vials will not end up in the special waste bins.
This is the region's anti-waste line Lazio which, in the wake of the Israeli model, aims not to throw away even a drop of serum and to cut waiting times. In short, the vaccine reserves run out on the “bench” waiting for a last minute call which, once opened, would inevitably end up being thrown away.
Read also: Pfizer and Moderna anti-Covid vaccines: what are the differences and how they work
“We can't waste a single dose. For this reason, after having consulted in videoconference with Israeli colleagues, we have imported a device that will allow us to make each vial 100% anti-Covid ”, explains the councilor for health Alessio D'Amato at the Repubblica edition of Rome.
How it works
According to the protocol, the Pfizer and Moderna doses not administered at the end of the day are entrusted to the so-called Uscar - the Special Regional Assistance Continuity Units, doctors and nurses against Covid-19 - and delivered to the over 80s who have already booked. vaccination.
The Lazio region's anti-waste line is inspired by the Israeli model and is necessary to avoid waste and cut waiting times.
"The tables that have shown us during the meetings - continues D'Amato - show that every day between 8 and 10% of those who have booked for the administration do not show up for the appointment".
In doing so, with the benches, we arrived at the administration of 46 doses that otherwise would have remained unused.
Source: la Repubblica Roma
- The EMA also gives the green light to AstraZeneca's Covid-19 vaccine in the EU
- Ema gives green light to BioNTech and Pfizer vaccine in Europe
- EMA gives green light to Moderna vaccine in Europe